Outlook for the next 5 years in drug innovation
Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.
Gespeichert in:
| Veröffentlicht in: | Nature reviews. Drug discovery 2012-06, Vol.11 (6), p.435-436 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 436 |
|---|---|
| container_issue | 6 |
| container_start_page | 435 |
| container_title | Nature reviews. Drug discovery |
| container_volume | 11 |
| creator | Berggren, Roy Møller, Martin Moss, Rachel Poda, Pawel Smietana, Katarzyna |
| description | Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually. |
| doi_str_mv | 10.1038/nrd3744 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1018359230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A293353459</galeid><sourcerecordid>A293353459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-78fe31372599e3298fed6576464b465c0d047bccb5bcb9f4d2e0ac753a6fc6913</originalsourceid><addsrcrecordid>eNptkU1LAzEQhoMotlbxH8iCB71sm-9sjqX4BQUvel6y2Wzduk1qsiv235vS2lqRHCaZeebNDC8AlwgOESTZyPqSCEqPQB9RQVMkMnq8uwveA2chzCFEHAl8CnoYc0YwzPpg9Ny1jXPvSeV80r6ZxJqvNmHJyigfktompe9mMVr3qdra2XNwUqkmmIttHIDX-7uXyWM6fX54moynqaaCtanIKkMQEZhJaQiW8VlyJjjltKCcaVhCKgqtC1boQla0xAYqLRhRvNJcIjIAtxvdpXcfnQltvqiDNk2jrHFdyBFEGWESExjR6z_o3HXexunWlKQQI4L31Ew1Jq9t5Vqv9Fo0H2NJCCOUyUgN_6HiKc2i1s6aqo75g4abTYP2LgRvqnzp64Xyq_h3vrYm31oTyavtmF2xMOWO-_Fiv3KIJTsz_vceh1rf7xGSUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1019402132</pqid></control><display><type>article</type><title>Outlook for the next 5 years in drug innovation</title><source>MEDLINE</source><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Berggren, Roy ; Møller, Martin ; Moss, Rachel ; Poda, Pawel ; Smietana, Katarzyna</creator><creatorcontrib>Berggren, Roy ; Møller, Martin ; Moss, Rachel ; Poda, Pawel ; Smietana, Katarzyna</creatorcontrib><description>Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.</description><identifier>ISSN: 1474-1776</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/nrd3744</identifier><identifier>PMID: 22653208</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/154/433 ; 631/154/51 ; 66 ; Antineoplastic Agents - economics ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Biological Products ; Biomedical and Life Sciences ; Biomedicine ; Biotechnology ; Cancer Research ; Diffusion of Innovation ; Drug Discovery - economics ; Drug Discovery - trends ; Drug Industry - trends ; Economics, Pharmaceutical ; from-the-analysts-couch ; Humans ; Industry sales and revenue ; Investments ; Medicinal Chemistry ; Molecular Medicine ; Pharmaceutical industry ; Pharmaceutical research ; Pharmacology/Toxicology ; Small Molecule Libraries</subject><ispartof>Nature reviews. Drug discovery, 2012-06, Vol.11 (6), p.435-436</ispartof><rights>Springer Nature Limited 2012</rights><rights>COPYRIGHT 2012 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jun 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-78fe31372599e3298fed6576464b465c0d047bccb5bcb9f4d2e0ac753a6fc6913</citedby><cites>FETCH-LOGICAL-c475t-78fe31372599e3298fed6576464b465c0d047bccb5bcb9f4d2e0ac753a6fc6913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nrd3744$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nrd3744$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22653208$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berggren, Roy</creatorcontrib><creatorcontrib>Møller, Martin</creatorcontrib><creatorcontrib>Moss, Rachel</creatorcontrib><creatorcontrib>Poda, Pawel</creatorcontrib><creatorcontrib>Smietana, Katarzyna</creatorcontrib><title>Outlook for the next 5 years in drug innovation</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><addtitle>Nat Rev Drug Discov</addtitle><description>Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.</description><subject>631/154/433</subject><subject>631/154/51</subject><subject>66</subject><subject>Antineoplastic Agents - economics</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological Products</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Cancer Research</subject><subject>Diffusion of Innovation</subject><subject>Drug Discovery - economics</subject><subject>Drug Discovery - trends</subject><subject>Drug Industry - trends</subject><subject>Economics, Pharmaceutical</subject><subject>from-the-analysts-couch</subject><subject>Humans</subject><subject>Industry sales and revenue</subject><subject>Investments</subject><subject>Medicinal Chemistry</subject><subject>Molecular Medicine</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceutical research</subject><subject>Pharmacology/Toxicology</subject><subject>Small Molecule Libraries</subject><issn>1474-1776</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkU1LAzEQhoMotlbxH8iCB71sm-9sjqX4BQUvel6y2Wzduk1qsiv235vS2lqRHCaZeebNDC8AlwgOESTZyPqSCEqPQB9RQVMkMnq8uwveA2chzCFEHAl8CnoYc0YwzPpg9Ny1jXPvSeV80r6ZxJqvNmHJyigfktompe9mMVr3qdra2XNwUqkmmIttHIDX-7uXyWM6fX54moynqaaCtanIKkMQEZhJaQiW8VlyJjjltKCcaVhCKgqtC1boQla0xAYqLRhRvNJcIjIAtxvdpXcfnQltvqiDNk2jrHFdyBFEGWESExjR6z_o3HXexunWlKQQI4L31Ew1Jq9t5Vqv9Fo0H2NJCCOUyUgN_6HiKc2i1s6aqo75g4abTYP2LgRvqnzp64Xyq_h3vrYm31oTyavtmF2xMOWO-_Fiv3KIJTsz_vceh1rf7xGSUA</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Berggren, Roy</creator><creator>Møller, Martin</creator><creator>Moss, Rachel</creator><creator>Poda, Pawel</creator><creator>Smietana, Katarzyna</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Outlook for the next 5 years in drug innovation</title><author>Berggren, Roy ; Møller, Martin ; Moss, Rachel ; Poda, Pawel ; Smietana, Katarzyna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-78fe31372599e3298fed6576464b465c0d047bccb5bcb9f4d2e0ac753a6fc6913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/154/433</topic><topic>631/154/51</topic><topic>66</topic><topic>Antineoplastic Agents - economics</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological Products</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Cancer Research</topic><topic>Diffusion of Innovation</topic><topic>Drug Discovery - economics</topic><topic>Drug Discovery - trends</topic><topic>Drug Industry - trends</topic><topic>Economics, Pharmaceutical</topic><topic>from-the-analysts-couch</topic><topic>Humans</topic><topic>Industry sales and revenue</topic><topic>Investments</topic><topic>Medicinal Chemistry</topic><topic>Molecular Medicine</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceutical research</topic><topic>Pharmacology/Toxicology</topic><topic>Small Molecule Libraries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berggren, Roy</creatorcontrib><creatorcontrib>Møller, Martin</creatorcontrib><creatorcontrib>Moss, Rachel</creatorcontrib><creatorcontrib>Poda, Pawel</creatorcontrib><creatorcontrib>Smietana, Katarzyna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berggren, Roy</au><au>Møller, Martin</au><au>Moss, Rachel</au><au>Poda, Pawel</au><au>Smietana, Katarzyna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outlook for the next 5 years in drug innovation</atitle><jtitle>Nature reviews. Drug discovery</jtitle><stitle>Nat Rev Drug Discov</stitle><addtitle>Nat Rev Drug Discov</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>11</volume><issue>6</issue><spage>435</spage><epage>436</epage><pages>435-436</pages><issn>1474-1776</issn><eissn>1474-1784</eissn><abstract>Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>22653208</pmid><doi>10.1038/nrd3744</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1474-1776 |
| ispartof | Nature reviews. Drug discovery, 2012-06, Vol.11 (6), p.435-436 |
| issn | 1474-1776 1474-1784 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1018359230 |
| source | MEDLINE; Nature; SpringerLink Journals - AutoHoldings |
| subjects | 631/154/433 631/154/51 66 Antineoplastic Agents - economics Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Biological Products Biomedical and Life Sciences Biomedicine Biotechnology Cancer Research Diffusion of Innovation Drug Discovery - economics Drug Discovery - trends Drug Industry - trends Economics, Pharmaceutical from-the-analysts-couch Humans Industry sales and revenue Investments Medicinal Chemistry Molecular Medicine Pharmaceutical industry Pharmaceutical research Pharmacology/Toxicology Small Molecule Libraries |
| title | Outlook for the next 5 years in drug innovation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A02%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outlook%20for%20the%20next%205%20years%20in%20drug%20innovation&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Berggren,%20Roy&rft.date=2012-06-01&rft.volume=11&rft.issue=6&rft.spage=435&rft.epage=436&rft.pages=435-436&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/nrd3744&rft_dat=%3Cgale_proqu%3EA293353459%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1019402132&rft_id=info:pmid/22653208&rft_galeid=A293353459&rfr_iscdi=true |